TRial on the Endocrine Activity of Neoadjuvant Degarelix
Status:
Completed
Trial end date:
2017-08-25
Target enrollment:
Participant gender:
Summary
The purpose of the this study is to investigate the anti-tumor activity and tolerability of
the study medications Degarelix and Triptorelin in premenopausal women receiving preoperative
treatment with Letrozole.